Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of nfκB

Journal of Vascular Research

Volumn 47, Issue 4, 2010, Pages 287-298

  Lee, Mary Y K ^a   Wang, Yu ^a   Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endothelial cells; eNOS; NF B; Oxidative stress; p53; Senescence

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; LIPID; NITRIC OXIDE; SOMATOMEDIN; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CORONARY ARTERIAL ENDOTHELIAL CELL; CORONARY ARTERY; CYTOSKELETON; ENDOTHELIUM CELL; FEMALE; GENOMICS; NONHUMAN; OXIDATIVE STRESS; PORCINE ADENOVIRUS; PRIORITY JOURNAL; PROTEOMICS; SENESCENCE; SWINE;

ANIMALS; ANTIOXIDANTS; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METALLOPORPHYRINS; NF-KAPPA B; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SUS SCROFA; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 72049129981     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265563     Document Type: Article

References (46)

1. Lee MYK, Tse HF, Siu CW, Zhu SG, Man RYK, Vanhoutte PM: Genomic changes in regenerated porcine coronary arterial endo-thelial cells. Arterioscler Thromb Vasc Biol 2007; 27: 2443-2449.
2. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP, Leonce S, Saboureau D, De-lescluse I, Vilaine JP, Vanhoutte PM: Pheno-typic and functional changes in regenerated porcine coronary endothelial cells: increased uptake of modified LDL and reduced production of NO. Circ Res 2000; 86:854-861.
3. Vanhoutte PM, Fournet-Bourguignon MP, Vilaine JP: Dysfonction de la voie du monoxide d'azote au cours de la régénération de l'endothélium coronarien. Académie Natio-nale de Médecine 2002; 186:1525-1541.
4. Brandes RP, Fleming I, Busse R: Endothelial aging. Cardiovasc Res 2005; 66: 286-294.
5. Erusalimsky JD, Kurz DJ: Cellular senescence in vivo: Its relevance in ageing and car-diovascula r disease. Exp Gerontol 2005; 40: 634-642.
6. Kudo FA, Warycha B, Juran PJ, Asada H, Teso D, Aziz F, Frattini J, Sumpio BE, Nishi-be T, Cha C, Dardik A: Differential responsiveness of early-and late-passage endothe-lial cells to shear stress. Am J Surg. 2005; 190: 763-769. (Pubitemid 41446502)
7. Minamino T, Komuro I: Vascular cell senescence: contribution to atherosclerosis. Circ Res 2007; 100: 15-26.
8. Shi Q, Hubbard GB, Kushwaha RS, Rainwater D, Thomas CA, Leland MM, Vandeberg JL, Wang XL: Endothelial senescence after high-cholesterol, high-fat diet challenge in baboons. Am J Physiol Heart Circ Physiol 2007; 292:H2913-H2920.
9. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamala-nat han S, Hat tori Y, Ig na rro LJ, Ig uchi A: En-dothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA 2006; 103:17018-17023.
10. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD: Microarray analysis of replicative senescence. Curr Biol 1999: 9:939-945.
11. Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M, Ouchi Y: Cilostazol inhibits ox-idative stress-induced premature senescence via upregulation of Sirt1 in human endothe-lial cells. Arterioscler Thromb Vasc Biol 2008; 28:1634-1639.
12. Shi Y, So KF, Man RY, Vanhoutte PM: Oxygen-derived free radicals mediate endotheli-um-dependent contractions in femoral arteries of rats with streptozotocin-induced di-abetes. Br J Pharmacol 2007; 152:1033-1041.
13. Kueng W, Silber E, Eppenberger U: Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182:16-19.
14. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler S: Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004; 94: 76 8-775.
15. Kurz DJ, Hong Y, Trivier E, Huang HL, De-cary S, Zang GH, Lüscher TF, Erusalimsky JD: Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23:748-75 4.
16. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA: Nitration and inactivation of manganese superoxide dis-mutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996; 93: 11853-11858.
17. Marumo T, Schini-Kerth VB, Busse R: Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48:1131-1137.
18. Shi Q, Aida K, Vandeberg JL, Wang XL: Passage-dependent changes in baboon endothe-lial cells: relevance to in vitro aging. DNA Cell Biol 2004; 23: 502-509.
19. Maniatis NA, Brovkovych V, Allen SE, John TA, Shajahan AN, Tiruppathi C, Vogel SM, Skidgel RA, Malik AB, Minshall RD: Novel mechanism of endothelial nitric oxide syn-thase activation mediated by caveolae inter-nalization in endothelial cells. Circ Res 2006; 99:870-877.
20. 2+ signals and gap junction function are regulated by caveolin in endo-thelial cells. Circulation 2008; 117: 1065-1074.
21. Hong Y, Quintero M, Frakich NM, Trivier E, Erusalimsky JD: Evidence against the involvement of nitric oxide in the modulation of telomerase activity or replicative capacity of human endothelial cells. Exp Gerontol 2007; 42:904-910.
22. Shimokawa H, Flavahan NA, Vanhoutte PM: Natural course of the impairment of endo-thelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries: possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 1989; 65: 740-753.
23. Gorgoulis VG, Pratsinis H, Zacharatos P, Demol iou C, Si ga l a F, A si ma c op ou lo s PJ, Pa-pavassiliou AG, Kletsas D: p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest 2005; 85: 502-511.
24. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G: DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 2006; 17: 1583-1592.
25. Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, Dos-tal C, Bosak V, Rychlik I, Cerna M: NFkap-paB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol 2006; 67:706-713.
26. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, Seals DR: Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired en-dothelium-dependent dilation and upregu-lation of nuclear factor-kappaB. Circ Res 2007; 100:1659-166 6.
27. Delafontaine P, Song YH, Li Y: Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004; 24: 435-444.
28. Thum T, Hoeber S, Froese S, Klink I, Stich-tenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J: Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007; 100:434-443.
29. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi T, Saiki I: Tumor Necrosis Factor-alpha-induced IKK phos-phorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 2003; 278: 36916-36923.
30. Zirlik A, Bavendiek U, Libby P, MacFarlane L, Gerdes N, Jagielska J, Ernst S, Aikawa M, Nakano H, Tsitsikov E, Schönbeck U: TRAF-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in en-dothelial cells. Arterioscler Thromb Vasc Biol 20 07; 27: 110 1-110 7.
31. Helenius M, Kyrylenko S, Vehviläinen P, Sal-minen A: Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid Redox Signal 2001; 3: 14 7-1 5 6.
32. Han ES, Muller FL, Perez VI, Qi W, Liang HY, Xi L, Fu C, Doyle E, Hickey M, Cornell J, Epstein CJ, Roberts LJ, Van Remmen H, Richardson A: The in vivo gene expression signature of oxidative stress. Physiol Ge-nomics 2008; 34:112-126.
33. Trougakos IP, Gonos ES: Regulation of clus-terin/apolipoprotein J, a functional homo-logue to the small heat shock proteins, by ox-idative stress in ageing and age-related diseases. Free Radic Res 2006; 40: 1324-1334.
34. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
35. Marfella R, Di Filippo C, Laieta MT, Vestini R, Barbieri M, Sangiulo P, Crescenzi B, Fer-raraccio F, Rossi F, D'Amico M, Paolisso G: Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients. J A Biol Sci Med Sci 2008; 63:200-203.
36. Lee MYK, Sørensen GL, Holmskov U, Van-houtte PM: The presence and activity of SP-D in porcine coronary endothelial cells depend on Akt/PI3K, Erk and nitric oxide and decrease after multiple passaging. Mol Immunol 2009; 46: 1050-1057.
37. Ohashi M, Runge MS, Faraci FM, Heistad DD: MnSOD deficiency increases endothe-lial dysfunction in ApoE-deficient mice. Ar-terioscler Thromb Vasc Biol 2006; 26:2331-2336.
38. Zhang LN, Velichko S, Vincelette J, Fitch RM, Vergona R, Sullivan ME, Croze E, Wang YX: Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis 2008; 197:204-211.
39. Busuttil RA, Rubio M, Dolle ME, Campisi J, Vijg J: Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell 20 03; 2: 287-605.
40. Fu Y, Luo N, Lopes-Virella MF, Garvey WT: The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 2002; 165:259-269.
41. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS: Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000; 14 1: 3388-3396.
42. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS: Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 1686-1691.
43. Furuhashi M, Tuncman G, Gorgun CZ, Ma-kowski L, Atsumi G, Vaillancourt E, Kono K, Babaev V R, Fa zio S, Li nton M, Sulsky R, Robl JA, Parker RA, Hotamisligil GS: Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007; 447:959-965.
44. Exil VJ, Roberts RL, Sims H, McLaughlin JE, Malkin RA, Gardner CD, Ni G, Rottman JN, St rauss AW: Very-long-cha in acyl-coenz y me a dehydrogenase deficiency in mice. Circ Res 2003; 93:448-455.
45. Catar RA, Müller G, Heidler J, Schmitz G, Bornstein SR, Morawietz H: Low-density li-poproteins induce the renin-angiotensin system and their receptors in human endo-thelial cells. Horm Metab Res 2007; 39: 801-805.
46. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, van der West-huyzen DR: SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 1998; 273: 15241-1524 8.